New Clinical Evidence Underscores Strong Adoption of MolecuLight’s Wound Imaging Platform to Improve Clinical Decision-Making and Achieve Outstanding Patient Outcomes TORONTO and ORLANDO, Fla., May 14, 2024 /PRNewswire/ – MolecuLight Inc., the pioneer in point-of-care fluorescence imaging…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.